Business
Novo Nordisk Shares Drop After Ziltivekimab Fails To Cut Major Heart Events
Shareholders reacted as Novo Nordisk’s experimental drug ziltivekimab failed to produce a statistically meaningful reduction in major cardiovascular
Microsoft Gains 15% While Meta Falls 8% After AI Revenue Split and Cash‑Flow Miss
Microsoft climbed 15% on Azure and Copilot momentum. Meta sank 8% after missing revenue guidance and a plunge in free cash flow.
Investors Lose As SK Hynix And Samsung Shares Plunge On AI Demand Fears
Sharp falls in SK Hynix and Samsung have wiped recent gains, stoking doubts about AI spending, chip supply and valuations.